These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23990182)

  • 21. Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy.
    Mittal S; Musat DL; Hoskins MH; Prillinger JB; Roberts GJ; Nabutovsky Y; Merchant FM
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29180458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrioventricular nodal ablation in patients with resynchronization therapy and atrial fibrillation - long term results.
    Aune A; Færestrand S; Hoff PI; Schuster P
    Scand Cardiovasc J; 2017 Jun; 51(3):138-142. PubMed ID: 28345365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up in AV junction ablation via the SVC in patients undergoing concurrent device implantation: a single center experience.
    Issa ZF; Amr BS; Laham H
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):254-8. PubMed ID: 25318466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation.
    Tan ES; Rienstra M; Wiesfeld AC; Schoonderwoerd BA; Hobbel HH; Van Gelder IC
    Europace; 2008 Apr; 10(4):412-8. PubMed ID: 18272509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: the need for large-scale randomized trials.
    Bradley DJ; Shen WK
    Heart Rhythm; 2007 Feb; 4(2):224-32. PubMed ID: 17275763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial Fibrillation During Cardiac Resynchronization Therapy.
    Kloosterman M; Maass AH; Rienstra M; Van Gelder IC
    Card Electrophysiol Clin; 2015 Dec; 7(4):735-48. PubMed ID: 26596815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac resynchronization therapy and atrial fibrillation.
    Kamath GS; Steinberg JS
    Cardiol J; 2009; 16(1):4-10. PubMed ID: 19130410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS.
    Brignole M; Pokushalov E; Pentimalli F; Palmisano P; Chieffo E; Occhetta E; Quartieri F; Calò L; Ungar A; Mont L;
    Eur Heart J; 2018 Dec; 39(45):3999-4008. PubMed ID: 30165479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of fixed-rate vs. rate-RESPONSIve pacing on exercise capacity in patients with permanent, refractory atrial fibrillation and left ventricular dysfunction treated with atrioventricular junction aBLation and bivEntricular pacing (RESPONSIBLE): a prospective, multicentre, randomized, single-blind study.
    Palmisano P; Aspromonte V; Ammendola E; Dell'era G; Ziacchi M; Guerra F; Aquilani S; Maglia G; Del Giorno G; Giubertoni A; Boriani G; Capucci A; Pietro Ricci R; Accogli M;
    Europace; 2017 Mar; 19(3):414-420. PubMed ID: 26941340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation.
    Ozcan C; Jahangir A; Friedman PA; Patel PJ; Munger TM; Rea RF; Lloyd MA; Packer DL; Hodge DO; Gersh BJ; Hammill SC; Shen WK
    N Engl J Med; 2001 Apr; 344(14):1043-51. PubMed ID: 11287974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of clinical efficacy of 'Ablate and Pace' therapy in patients with permanent atrial fibrillation.
    Brignole M; Botto GL; Mont L; Oddone D; Iacopino S; De Marchi G; Campoli M; Sebastiani V; Vincenti A; Garcia Medina D; Osca Asensi J; Mocini A; Grovale N; De Santo T; Menozzi C
    Heart; 2012 Feb; 98(4):297-302. PubMed ID: 22095616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leadless pacemaker implantation and concurrent atrioventricular junction ablation in patients with atrial fibrillation.
    Okabe T; El-Chami MF; Lloyd MS; Buck B; Gornick CC; Moore JC; Augostini RS; Hummel JD
    Pacing Clin Electrophysiol; 2018 May; 41(5):504-510. PubMed ID: 29476660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of survival for cardiac resynchronization therapy in atrial fibrillation patients with or without atrio-ventricular junction ablation and patients in sinus rhythm: a systematic review and network meta-analysis.
    Xue Y; Wang J; Wang J; Thapa S; Huang K; Peng Y; Qian L; Li J; Ji K
    Heart Fail Rev; 2019 May; 24(3):335-342. PubMed ID: 30610455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
    Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does permanent atrial fibrillation modify response to cardiac resynchronization therapy in heart failure patients?
    Abreu A; Oliveira M; Silva Cunha P; Santa Clara H; Portugal G; Gonçalves Rodrigues I; Santos V; Morais L; Selas M; Soares R; Branco L; Ferreira R; Mota Carmo M;
    Rev Port Cardiol; 2017 Oct; 36(10):687-694. PubMed ID: 29031455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrioventricular junction ablation for atrial fibrillation.
    Patel D; Daoud EG
    Cardiol Clin; 2014 Nov; 32(4):573-83. PubMed ID: 25443238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac resynchronization therapy in patients with atrial fibrillation: a meta-analysis.
    Lopes C; Pereira T; Barra S
    Rev Port Cardiol; 2014 Nov; 33(11):717-25. PubMed ID: 25457476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review.
    Ganesan AN; Brooks AG; Roberts-Thomson KC; Lau DH; Kalman JM; Sanders P
    J Am Coll Cardiol; 2012 Feb; 59(8):719-26. PubMed ID: 22340263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of rate-controlled persistent atrial fibrillation with clinical outcome and ventricular remodelling in recipients of cardiac resynchronization therapy.
    Wilton SB; Kavanagh KM; Aggarwal SG; Philippon F; Yee R; Cowan K; Exner DV
    Can J Cardiol; 2011; 27(6):787-93. PubMed ID: 21908159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.